eCOA/ePRO Benchmarking & Market Dynamics (4th Ed.)

Description

There’s no question that technology is continuously becoming more prevalent in the clinical development space and electronic clinical outcomes assessments (eCOA) and electronic patient reported outcomes (ePRO) systems are no exception. Over the past several years, eCOA/ePRO systems are now considered the norm and are necessary tools to properly capture, review, and even present data collected throughout the course of a clinical trial. At ISR, we have been tracking the eCOA/ePRO market for over a decade and one thing is for certain – eCOA/ePRO applications are here to stay. As technology in the eCOA/ePRO space continues to change, more sponsors and CROs rely on these systems to ensure high quality data, lower costs, and fewer delays.
eCOA/ePRO providers and sponsor/CRO organizations will gain valuable insight using this research. For eCOA/ePRO providers: Learn how your company performs against competitors. Discover where performance exceeds expectations so you can differentiate your offerings from competitors. For sponsors/CROs: Compare your company’s outsourcing philosophy to that of the broader industry. Evaluate your provider selection process. Explore new providers and understand how they have performed for industry peers.

Preview cover for eCOA/ePRO Market Dynamics and Service Provider Performance (4th Edtition)

Sponsors and CROs:

  • Gain insight from 240 service provider encounters with 18 eCOA/ePRO systems
  • Get a bird’s eye view of the eCOA/ePRO market, including provider preference for development and late-stage trials, criteria used for provider selection, and service provider performance
  • Narrow down which eCOA/ePRO system might best fit your needs so you can make a more informed decision when selecting eCOA/ePRO services
  • Understand which eCOA/ePRO systems are being most utilized by your peers

Technology Providers:

  • Benchmark your performance against your competition
  • Anticipate how changes in trial volume and adoption/penetration will affect your future business opportunities
  • Identify operational improvements and product characteristics that impact trial success, especially device integration and user-friendliness
  • Understand your company’s and the competition’s position in the marketplace in terms of familiarity and use, and your company’s performance on 28 attributes across 6 categories relative to user expectations

Part I: Market Dynamics

  • Market Environment
  • Provider Selection Criteria
  • Study Data

Part II: Provider Performance

  • Provider Perceptions
  • Provider Performance
  • Attribute Performance

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

Sample Page "For eCOA/ePRO Project Managers" from eCOAePRO Market Dynamics and Service Provider Performance (4th Edition)

Part I: Market Dynamics

Market Environment

Primary Section Takeaways
Systems Usage
Preferred Provider Agreements
Preference for eCOA/ePRO vs. Paper Diaries
Use of Electronic Solutions vs. Paper
Preference for Device-based Interface
Use of Direct Data Capture Sensors/Wearables for Patient Measurements
Source of Clinical Reported Outcomes (Past and Projected)
Source of Clinical Outcomes Assessments
How to Improve Functionality of eCOA/ePRO Software Systems
Impact of eCOA/ePRO Product Attributes on Trial Success

Provider Selection Criteria

Primary Section Takeaways
Most Important Attributes for Provider Selection
Influencing Sponsor In-house Provider Selection
Influencing CRO Provider Selection
Influence of Sponsors on Provider Selection for Outsourced Studies

Study Data

Most Important Attributes for Provider Selection
Impact of eCOA/ePRO Product Attributes on Trial Success
Use of Electronic Solutions vs. Paper (Past and Projected)
Number of eCOA/ePRO Systems Used (Current and Projected)
Preferred Provider Agreements
Influencing Provider Selection (In-House Studies)
Influencing Provider Selection (CROs)
Influence of Sponsors on Provider Selection for Outsourced Studies
Contract Directly vs. through CRO for eCOA/ePRO Components
Sponsor Contract Directly with CRO vs. through eCOA/ePRO Provider
Preference for eCOA/ePRO vs. Paper Diaries
Preference for Device-based Interface
Knowledge of eCOA/ePRO Component Use in Clinical Trials
Percent of Trials Using eCOA/ePRO Component (Past and Projected)
Use of Direct Data Capture Sensors/Wearables for Patient Measurements (Past and Projected)
Source of Clinical Outcome Assessments (Past and Projected)
Source of Clinical Reported Outcomes (Past and Projected)
How to Improve Functionality of eCOA/ePRO Software Systems – Themed
Verbatim Responses: How to Improve Functionality of eCOA/ePRO Software Systems

Demographics

Company Type
Decision-making Responsibility
Type of Office/Practice
Most Recent Clinical Trial
Involvement in Clinical Trials (Past 12 months)
Role of Organization in Clinical Trial
Roles and Responsibilities
Office Location
Therapeutic Areas of Responsibility
Technology Familiarity

Part II: Provider Performance

Provider Perceptions

Primary Section Takeaways
Provider Usage and Familiarity
Past Use/Experience Level with Providers
Provider Preference by Trial Stage

Phase I and II Development Stage
Phase IIb and III Development Stage
Phase IV, Post-marketing Late-stage

Provider Performance

Primary Section Takeaways
A Note on Performance Calculations
Performance Across Service Providers
Figure 1 – Capabilities
Figure 2 – Cost
Figure 3 – System Flexibility and Support
Figure 4 – System/Device Integration
Figure 5 – Usability
Figure 6 – Validation and Patient Compliance

Company Service Quality Profiles

Almac
ERT
ICON
IQVIA
Medidata/Dassault Systemes (Rave)
Parexel
Signant Health (SmartSignals/TrialMax)

Attribute Performance

Almac
ArisGlobal (LifeSphere)
Clinical Ink
DataTrak (Direct)
ERT
ICON
IQVIA
Kayentis
Medable
MedAvante-Prophase, a WCG Company (Virgil PRO)
Medidata/Dassault Systemes (Rave)
Parexel
Signant Health (SmartSignals/TrialMax)
THREAD
uMotif
Viedoc (ViedocMe)
WCG (WIRB-Copernicus Group)
YPrime

Demographics

Company Type
Decision-making Responsibility (Sponsors)
Involvement in Clinical Trials (Past 12 months)
Type of Office/Practice
Most Recent Clinical Trial
Role of Organization in Clinical Trial
Roles and Responsibilities
Office Location
Therapeutic Areas of Responsibility
Technology Familiarity

Additional information

License

, ,